JP2017527775A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017527775A5 JP2017527775A5 JP2016570087A JP2016570087A JP2017527775A5 JP 2017527775 A5 JP2017527775 A5 JP 2017527775A5 JP 2016570087 A JP2016570087 A JP 2016570087A JP 2016570087 A JP2016570087 A JP 2016570087A JP 2017527775 A5 JP2017527775 A5 JP 2017527775A5
- Authority
- JP
- Japan
- Prior art keywords
- mir
- use according
- tamoxifen
- therapeutic agent
- individual
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims 12
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 claims 11
- 229940124597 therapeutic agent Drugs 0.000 claims 11
- 239000000090 biomarker Substances 0.000 claims 4
- -1 miR-27a Proteins 0.000 claims 4
- MHJBZVSGOZTKRH-IZHYLOQSSA-N 4-Hydroxy-N-desmethyltamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCNC)=CC=1)/C1=CC=C(O)C=C1 MHJBZVSGOZTKRH-IZHYLOQSSA-N 0.000 claims 3
- 239000012530 fluid Substances 0.000 claims 3
- 108091070501 miRNA Proteins 0.000 claims 3
- 239000002679 microRNA Substances 0.000 claims 3
- 229960001603 tamoxifen Drugs 0.000 claims 3
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 claims 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims 2
- 230000007067 DNA methylation Effects 0.000 claims 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims 2
- VWUXBMIQPBEWFH-WCCTWKNTSA-N Fulvestrant Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)CC2=C1 VWUXBMIQPBEWFH-WCCTWKNTSA-N 0.000 claims 2
- NYDCDZSEEAUOHN-IZHYLOQSSA-N N-Desmethyltamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCNC)=CC=1)/C1=CC=CC=C1 NYDCDZSEEAUOHN-IZHYLOQSSA-N 0.000 claims 2
- 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 claims 2
- 102000012335 Plasminogen Activator Inhibitor 1 Human genes 0.000 claims 2
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 claims 2
- 230000005856 abnormality Effects 0.000 claims 2
- 239000012190 activator Substances 0.000 claims 2
- 210000000481 breast Anatomy 0.000 claims 2
- 229960004679 doxorubicin Drugs 0.000 claims 2
- 229960002258 fulvestrant Drugs 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 108091091751 miR-17 stem-loop Proteins 0.000 claims 2
- 108091029500 miR-183 stem-loop Proteins 0.000 claims 2
- 108091071822 miR-572 stem-loop Proteins 0.000 claims 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims 2
- 229960004622 raloxifene Drugs 0.000 claims 2
- GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 claims 2
- 229940095743 selective estrogen receptor modulator Drugs 0.000 claims 2
- 239000000333 selective estrogen receptor modulator Substances 0.000 claims 2
- XFCLJVABOIYOMF-QPLCGJKRSA-N toremifene Chemical compound C1=CC(OCCN(C)C)=CC=C1C(\C=1C=CC=CC=1)=C(\CCCl)C1=CC=CC=C1 XFCLJVABOIYOMF-QPLCGJKRSA-N 0.000 claims 2
- 229960005026 toremifene Drugs 0.000 claims 2
- AOJJSUZBOXZQNB-VTZDEGQISA-N 4'-epidoxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-VTZDEGQISA-N 0.000 claims 1
- 108010012934 Albumin-Bound Paclitaxel Proteins 0.000 claims 1
- BFYIZQONLCFLEV-DAELLWKTSA-N Aromasine Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC(=C)C2=C1 BFYIZQONLCFLEV-DAELLWKTSA-N 0.000 claims 1
- 229930003347 Atropine Natural products 0.000 claims 1
- GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 claims 1
- GAGWJHPBXLXJQN-UHFFFAOYSA-N Capecitabine Natural products C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1C1C(O)C(O)C(C)O1 GAGWJHPBXLXJQN-UHFFFAOYSA-N 0.000 claims 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 claims 1
- ZQZFYGIXNQKOAV-OCEACIFDSA-N Droloxifene Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=C(O)C=CC=1)\C1=CC=C(OCCN(C)C)C=C1 ZQZFYGIXNQKOAV-OCEACIFDSA-N 0.000 claims 1
- HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 claims 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims 1
- 108010069236 Goserelin Proteins 0.000 claims 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 claims 1
- JJKOTMDDZAJTGQ-DQSJHHFOSA-N Idoxifene Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN2CCCC2)=CC=1)/C1=CC=C(I)C=C1 JJKOTMDDZAJTGQ-DQSJHHFOSA-N 0.000 claims 1
- 208000037396 Intraductal Noninfiltrating Carcinoma Diseases 0.000 claims 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 claims 1
- 108091007774 MIR107 Proteins 0.000 claims 1
- 108091007772 MIRLET7C Proteins 0.000 claims 1
- 108091028080 MiR-132 Proteins 0.000 claims 1
- 108091028684 Mir-145 Proteins 0.000 claims 1
- 108091028049 Mir-221 microRNA Proteins 0.000 claims 1
- 108091027559 Mir-96 microRNA Proteins 0.000 claims 1
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 claims 1
- 108091033760 Oncomir Proteins 0.000 claims 1
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 claims 1
- 101800000989 Oxytocin Proteins 0.000 claims 1
- 102100031951 Oxytocin-neurophysin 1 Human genes 0.000 claims 1
- 229930012538 Paclitaxel Natural products 0.000 claims 1
- 241000282376 Panthera tigris Species 0.000 claims 1
- 108010066816 Polypeptide N-acetylgalactosaminyltransferase Proteins 0.000 claims 1
- 108700025695 Suppressor Genes Proteins 0.000 claims 1
- 229940123237 Taxane Drugs 0.000 claims 1
- 229930003316 Vitamin D Natural products 0.000 claims 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims 1
- 229960002932 anastrozole Drugs 0.000 claims 1
- YBBLVLTVTVSKRW-UHFFFAOYSA-N anastrozole Chemical compound N#CC(C)(C)C1=CC(C(C)(C#N)C)=CC(CN2N=CN=C2)=C1 YBBLVLTVTVSKRW-UHFFFAOYSA-N 0.000 claims 1
- 229940045799 anthracyclines and related substance Drugs 0.000 claims 1
- 230000000259 anti-tumor effect Effects 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- MCGDSOGUHLTADD-UHFFFAOYSA-N arzoxifene Chemical compound C1=CC(OC)=CC=C1C1=C(OC=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 MCGDSOGUHLTADD-UHFFFAOYSA-N 0.000 claims 1
- 229950005529 arzoxifene Drugs 0.000 claims 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 claims 1
- 229960000396 atropine Drugs 0.000 claims 1
- VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 claims 1
- UCJGJABZCDBEDK-UHFFFAOYSA-N bazedoxifene Chemical compound C=1C=C(OCCN2CCCCCC2)C=CC=1CN1C2=CC=C(O)C=C2C(C)=C1C1=CC=C(O)C=C1 UCJGJABZCDBEDK-UHFFFAOYSA-N 0.000 claims 1
- 229960000817 bazedoxifene Drugs 0.000 claims 1
- 229960004117 capecitabine Drugs 0.000 claims 1
- 229960004562 carboplatin Drugs 0.000 claims 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims 1
- 229960004316 cisplatin Drugs 0.000 claims 1
- GKIRPKYJQBWNGO-OCEACIFDSA-N clomifene Chemical compound C1=CC(OCCN(CC)CC)=CC=C1C(\C=1C=CC=CC=1)=C(\Cl)C1=CC=CC=C1 GKIRPKYJQBWNGO-OCEACIFDSA-N 0.000 claims 1
- 229960003608 clomifene Drugs 0.000 claims 1
- 229960004397 cyclophosphamide Drugs 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims 1
- 229960003668 docetaxel Drugs 0.000 claims 1
- 229950004203 droloxifene Drugs 0.000 claims 1
- 208000028715 ductal breast carcinoma in situ Diseases 0.000 claims 1
- 229960001904 epirubicin Drugs 0.000 claims 1
- 229960003649 eribulin Drugs 0.000 claims 1
- UFNVPOGXISZXJD-XJPMSQCNSA-N eribulin Chemical compound C([C@H]1CC[C@@H]2O[C@@H]3[C@H]4O[C@H]5C[C@](O[C@H]4[C@H]2O1)(O[C@@H]53)CC[C@@H]1O[C@H](C(C1)=C)CC1)C(=O)C[C@@H]2[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]2C[C@@H]2C(=C)[C@H](C)C[C@H]1O2 UFNVPOGXISZXJD-XJPMSQCNSA-N 0.000 claims 1
- 229960005167 everolimus Drugs 0.000 claims 1
- 229960000255 exemestane Drugs 0.000 claims 1
- 229960002949 fluorouracil Drugs 0.000 claims 1
- 229960005277 gemcitabine Drugs 0.000 claims 1
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 claims 1
- 229960003690 goserelin acetate Drugs 0.000 claims 1
- 229950002248 idoxifene Drugs 0.000 claims 1
- 229960002014 ixabepilone Drugs 0.000 claims 1
- FABUFPQFXZVHFB-CFWQTKTJSA-N ixabepilone Chemical compound C/C([C@@H]1C[C@@H]2O[C@]2(C)CCC[C@@H]([C@@H]([C@H](C)C(=O)C(C)(C)[C@H](O)CC(=O)N1)O)C)=C\C1=CSC(C)=N1 FABUFPQFXZVHFB-CFWQTKTJSA-N 0.000 claims 1
- 229960001320 lapatinib ditosylate Drugs 0.000 claims 1
- 229960002367 lasofoxifene Drugs 0.000 claims 1
- GXESHMAMLJKROZ-IAPPQJPRSA-N lasofoxifene Chemical compound C1([C@@H]2[C@@H](C3=CC=C(C=C3CC2)O)C=2C=CC(OCCN3CCCC3)=CC=2)=CC=CC=C1 GXESHMAMLJKROZ-IAPPQJPRSA-N 0.000 claims 1
- 230000003902 lesion Effects 0.000 claims 1
- 108091063986 let-7f stem-loop Proteins 0.000 claims 1
- 229960003881 letrozole Drugs 0.000 claims 1
- HPJKCIUCZWXJDR-UHFFFAOYSA-N letrozole Chemical compound C1=CC(C#N)=CC=C1C(N1N=CN=C1)C1=CC=C(C#N)C=C1 HPJKCIUCZWXJDR-UHFFFAOYSA-N 0.000 claims 1
- 238000009607 mammography Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229960004296 megestrol acetate Drugs 0.000 claims 1
- RQZAXGRLVPAYTJ-GQFGMJRRSA-N megestrol acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RQZAXGRLVPAYTJ-GQFGMJRRSA-N 0.000 claims 1
- 229960000485 methotrexate Drugs 0.000 claims 1
- 239000012022 methylating agents Substances 0.000 claims 1
- 108091045790 miR-106b stem-loop Proteins 0.000 claims 1
- 108091054042 miR-1207 stem-loop Proteins 0.000 claims 1
- 108091056924 miR-124 stem-loop Proteins 0.000 claims 1
- 108091091360 miR-125b stem-loop Proteins 0.000 claims 1
- 108091074816 miR-1268 stem-loop Proteins 0.000 claims 1
- 108091046573 miR-1275 stem-loop Proteins 0.000 claims 1
- 108091070946 miR-128 stem-loop Proteins 0.000 claims 1
- 108091040501 miR-129 stem-loop Proteins 0.000 claims 1
- 108091045757 miR-129-3 stem-loop Proteins 0.000 claims 1
- 108091090758 miR-129-4 stem-loop Proteins 0.000 claims 1
- 108091065139 miR-129-5 stem-loop Proteins 0.000 claims 1
- 108091045872 miR-135 stem-loop Proteins 0.000 claims 1
- 108091026523 miR-135a stem-loop Proteins 0.000 claims 1
- 108091026375 miR-135b stem-loop Proteins 0.000 claims 1
- 108091086065 miR-135b-2 stem-loop Proteins 0.000 claims 1
- 108091058688 miR-141 stem-loop Proteins 0.000 claims 1
- 108091032320 miR-146 stem-loop Proteins 0.000 claims 1
- 108091024530 miR-146a stem-loop Proteins 0.000 claims 1
- 108091031326 miR-15b stem-loop Proteins 0.000 claims 1
- 108091044046 miR-17-1 stem-loop Proteins 0.000 claims 1
- 108091069239 miR-17-2 stem-loop Proteins 0.000 claims 1
- 108091065423 miR-17-3 stem-loop Proteins 0.000 claims 1
- 108091031103 miR-181a stem-loop Proteins 0.000 claims 1
- 108091046591 miR-181a-4 stem-loop Proteins 0.000 claims 1
- 108091049627 miR-181a-5 stem-loop Proteins 0.000 claims 1
- 108091023567 miR-1915 stem-loop Proteins 0.000 claims 1
- 108091063348 miR-193 stem-loop Proteins 0.000 claims 1
- 108091036762 miR-193a stem-loop Proteins 0.000 claims 1
- 108091039097 miR-193b stem-loop Proteins 0.000 claims 1
- 108091037787 miR-19b stem-loop Proteins 0.000 claims 1
- 108091087148 miR-20 stem-loop Proteins 0.000 claims 1
- 108091066984 miR-20-1 stem-loop Proteins 0.000 claims 1
- 108091076199 miR-20-2 stem-loop Proteins 0.000 claims 1
- 108091089775 miR-200b stem-loop Proteins 0.000 claims 1
- 108091074450 miR-200c stem-loop Proteins 0.000 claims 1
- 108091045665 miR-202 stem-loop Proteins 0.000 claims 1
- 108091031479 miR-204 stem-loop Proteins 0.000 claims 1
- 108091032382 miR-204-1 stem-loop Proteins 0.000 claims 1
- 108091085803 miR-204-2 stem-loop Proteins 0.000 claims 1
- 108091089766 miR-204-3 stem-loop Proteins 0.000 claims 1
- 108091073500 miR-204-4 stem-loop Proteins 0.000 claims 1
- 108091053626 miR-204-5 stem-loop Proteins 0.000 claims 1
- 108091049679 miR-20a stem-loop Proteins 0.000 claims 1
- 108091062762 miR-21 stem-loop Proteins 0.000 claims 1
- 108091041631 miR-21-1 stem-loop Proteins 0.000 claims 1
- 108091044442 miR-21-2 stem-loop Proteins 0.000 claims 1
- 108091056091 miR-2117 stem-loop Proteins 0.000 claims 1
- 108091061917 miR-221 stem-loop Proteins 0.000 claims 1
- 108091063489 miR-221-1 stem-loop Proteins 0.000 claims 1
- 108091055391 miR-221-2 stem-loop Proteins 0.000 claims 1
- 108091031076 miR-221-3 stem-loop Proteins 0.000 claims 1
- 108091092722 miR-23b stem-loop Proteins 0.000 claims 1
- 108091031298 miR-23b-1 stem-loop Proteins 0.000 claims 1
- 108091082339 miR-23b-2 stem-loop Proteins 0.000 claims 1
- 108091061970 miR-26a stem-loop Proteins 0.000 claims 1
- 108091088477 miR-29a stem-loop Proteins 0.000 claims 1
- 108091029716 miR-29a-1 stem-loop Proteins 0.000 claims 1
- 108091092089 miR-29a-2 stem-loop Proteins 0.000 claims 1
- 108091066559 miR-29a-3 stem-loop Proteins 0.000 claims 1
- 108091007432 miR-29b Proteins 0.000 claims 1
- 108091063344 miR-30b stem-loop Proteins 0.000 claims 1
- 108091057431 miR-30d stem-loop Proteins 0.000 claims 1
- 108091035428 miR-3143 stem-loop Proteins 0.000 claims 1
- 108091059493 miR-322 stem-loop Proteins 0.000 claims 1
- 108091031484 miR-335 stem-loop Proteins 0.000 claims 1
- 108091049667 miR-340 stem-loop Proteins 0.000 claims 1
- 108091057189 miR-340-2 stem-loop Proteins 0.000 claims 1
- 108091029119 miR-34a stem-loop Proteins 0.000 claims 1
- 108091036962 miR-3672 stem-loop Proteins 0.000 claims 1
- 108091027983 miR-378-1 stem-loop Proteins 0.000 claims 1
- 108091089716 miR-378-2 stem-loop Proteins 0.000 claims 1
- 108091048468 miR-383 stem-loop Proteins 0.000 claims 1
- 108091090987 miR-425 stem-loop Proteins 0.000 claims 1
- 108091040184 miR-43 stem-loop Proteins 0.000 claims 1
- 108091076357 miR-43-1 stem-loop Proteins 0.000 claims 1
- 108091037708 miR-43-2 stem-loop Proteins 0.000 claims 1
- 108091086430 miR-4324 stem-loop Proteins 0.000 claims 1
- 108091044133 miR-454 stem-loop Proteins 0.000 claims 1
- 108091042739 miR-49 stem-loop Proteins 0.000 claims 1
- 108091063340 miR-497 stem-loop Proteins 0.000 claims 1
- 108091090896 miR-506 stem-loop Proteins 0.000 claims 1
- 108091091625 miR-519c stem-loop Proteins 0.000 claims 1
- 108091026826 miR-519c-2 stem-loop Proteins 0.000 claims 1
- 108091031110 miR-539 stem-loop Proteins 0.000 claims 1
- 108091045812 miR-544b stem-loop Proteins 0.000 claims 1
- 108091076617 miR-544b-1 stem-loop Proteins 0.000 claims 1
- 108091050743 miR-544b-2 stem-loop Proteins 0.000 claims 1
- 108091069948 miR-548a-1 stem-loop Proteins 0.000 claims 1
- 108091073707 miR-548a-2 stem-loop Proteins 0.000 claims 1
- 108091034066 miR-548a-3 stem-loop Proteins 0.000 claims 1
- 108091068733 miR-548e stem-loop Proteins 0.000 claims 1
- 108091063333 miR-556 stem-loop Proteins 0.000 claims 1
- 108091071062 miR-557 stem-loop Proteins 0.000 claims 1
- 108091046865 miR-569 stem-loop Proteins 0.000 claims 1
- 108091023843 miR-575 stem-loop Proteins 0.000 claims 1
- 108091024411 miR-590 stem-loop Proteins 0.000 claims 1
- 108091024127 miR-634 stem-loop Proteins 0.000 claims 1
- 108091038240 miR-638 stem-loop Proteins 0.000 claims 1
- 108091049434 miR-644 stem-loop Proteins 0.000 claims 1
- 108091063911 miR-650 stem-loop Proteins 0.000 claims 1
- 108091092761 miR-671 stem-loop Proteins 0.000 claims 1
- 108091084058 miR-874 stem-loop Proteins 0.000 claims 1
- 108091058491 miR-877 stem-loop Proteins 0.000 claims 1
- 108091034121 miR-92a stem-loop Proteins 0.000 claims 1
- 108091041519 miR-92a-3 stem-loop Proteins 0.000 claims 1
- 108091032902 miR-93 stem-loop Proteins 0.000 claims 1
- 108091030513 miR-933 stem-loop Proteins 0.000 claims 1
- 108091086713 miR-96 stem-loop Proteins 0.000 claims 1
- 108091070961 miR-96-3 stem-loop Proteins 0.000 claims 1
- 108091024443 miRa-135-1 stem-loop Proteins 0.000 claims 1
- 229960001156 mitoxantrone Drugs 0.000 claims 1
- KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 claims 1
- AZBFJBJXUQUQLF-UHFFFAOYSA-N n-(1,5-dimethylpyrrolidin-3-yl)pyrrolidine-1-carboxamide Chemical compound C1N(C)C(C)CC1NC(=O)N1CCCC1 AZBFJBJXUQUQLF-UHFFFAOYSA-N 0.000 claims 1
- QCQYVCMYGCHVMR-AAZUGDAUSA-N n-[(2r,3r,4s,5r)-4,5,6-trihydroxy-1-oxo-3-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide Chemical compound CC(=O)N[C@@H](C=O)[C@H]([C@@H](O)[C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O QCQYVCMYGCHVMR-AAZUGDAUSA-N 0.000 claims 1
- BLCLNMBMMGCOAS-UHFFFAOYSA-N n-[1-[[1-[[1-[[1-[[1-[[1-[[1-[2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amin Chemical compound C1CCC(C(=O)NNC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(COC(C)(C)C)NC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 BLCLNMBMMGCOAS-UHFFFAOYSA-N 0.000 claims 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims 1
- 229940012843 omega-3 fatty acid Drugs 0.000 claims 1
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 claims 1
- 229960001723 oxytocin Drugs 0.000 claims 1
- 229960001592 paclitaxel Drugs 0.000 claims 1
- WRUUGTRCQOWXEG-UHFFFAOYSA-N pamidronate Chemical compound NCCC(O)(P(O)(O)=O)P(O)(O)=O WRUUGTRCQOWXEG-UHFFFAOYSA-N 0.000 claims 1
- 229960002087 pertuzumab Drugs 0.000 claims 1
- 229910052697 platinum Inorganic materials 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229940125944 selective estrogen receptor degrader Drugs 0.000 claims 1
- 230000003584 silencer Effects 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 claims 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 1
- 229960001612 trastuzumab emtansine Drugs 0.000 claims 1
- GBABOYUKABKIAF-GHYRFKGUSA-N vinorelbine Chemical compound C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC GBABOYUKABKIAF-GHYRFKGUSA-N 0.000 claims 1
- 229960002066 vinorelbine Drugs 0.000 claims 1
- 235000019166 vitamin D Nutrition 0.000 claims 1
- 239000011710 vitamin D Substances 0.000 claims 1
- 229940046008 vitamin d Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462007830P | 2014-06-04 | 2014-06-04 | |
| US62/007,830 | 2014-06-04 | ||
| PCT/US2015/033827 WO2015187727A2 (en) | 2014-06-04 | 2015-06-02 | Molecular mammography |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017527775A JP2017527775A (ja) | 2017-09-21 |
| JP2017527775A5 true JP2017527775A5 (https=) | 2018-07-12 |
| JP6757935B2 JP6757935B2 (ja) | 2020-09-23 |
Family
ID=54767566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016570087A Expired - Fee Related JP6757935B2 (ja) | 2014-06-04 | 2015-06-02 | 分子マンモグラフィ |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20170145515A1 (https=) |
| EP (1) | EP3152579A4 (https=) |
| JP (1) | JP6757935B2 (https=) |
| CN (1) | CN107076747B (https=) |
| WO (1) | WO2015187727A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107012199A (zh) * | 2016-01-28 | 2017-08-04 | 上海市东方医院 | 一种在血浆和血清中检测miRNA的方法 |
| JP6980219B2 (ja) * | 2016-08-22 | 2021-12-15 | いであ株式会社 | がんを検出、又はがんの進行期を判定する方法 |
| WO2018098379A1 (en) * | 2016-11-22 | 2018-05-31 | Prime Genomics, Inc. | Methods for cancer detection |
| TWI793165B (zh) | 2017-09-11 | 2023-02-21 | 美商阿托薩醫療公司 | 製造及使用因多昔芬(endoxifen)之方法 |
| JP7108715B2 (ja) * | 2018-01-25 | 2022-07-28 | パー ホール | 乳房障害の治療をモニターするための組成物および方法 |
| GB201907999D0 (en) * | 2019-06-05 | 2019-07-17 | Cambridge Entpr | Breast cancer detection methods |
| MX2022000203A (es) | 2019-07-03 | 2022-03-22 | Atossa Therapeutics Inc | Composiciones de liberacion sostenida de endoxifeno. |
| CN110760513A (zh) * | 2019-08-23 | 2020-02-07 | 西北工业大学 | 靶向三阴性乳腺癌细胞PENK基因的miR-506及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5798266A (en) * | 1996-08-27 | 1998-08-25 | K-Quay Enterprises, Llc | Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer |
| WO2003042660A2 (en) * | 2001-11-14 | 2003-05-22 | Sirbasku David A | Screening method for predicting susceptibility to breast cancer |
| CA2477828A1 (en) * | 2002-03-15 | 2003-09-25 | Cytyc Health Corporation | Method of diagnosis and treatment of breast lesions |
| WO2007140352A2 (en) * | 2006-05-26 | 2007-12-06 | Invitrogen Corporation | Plasma membrane and secreted cancer biomarkers |
| US8738124B2 (en) * | 2007-12-11 | 2014-05-27 | Epi-Sci, Llc | Electrical bioimpedance analysis as a biomarker of breast density and/or breast cancer risk |
| EP2358912B1 (en) * | 2008-10-30 | 2016-10-12 | Caris Life Sciences Switzerland Holdings GmbH | Methods for assessing rna patterns |
| GB2463401B (en) * | 2008-11-12 | 2014-01-29 | Caris Life Sciences Luxembourg Holdings S A R L | Characterizing prostate disorders by analysis of microvesicles |
| WO2011137288A2 (en) * | 2010-04-30 | 2011-11-03 | The Ohio State University | Mirna networks in cancers and leukemias and uses thereof |
| WO2013063147A1 (en) * | 2011-10-24 | 2013-05-02 | Atossa Genetics, Inc. | Absorbent paper and use thereof for breast cancer detection |
| US20130115629A1 (en) * | 2011-10-24 | 2013-05-09 | Atossa Genetics, Inc. | Methods of breast cancer detection |
-
2015
- 2015-06-02 CN CN201580039837.XA patent/CN107076747B/zh not_active Expired - Fee Related
- 2015-06-02 EP EP15803028.8A patent/EP3152579A4/en not_active Withdrawn
- 2015-06-02 US US15/316,136 patent/US20170145515A1/en not_active Abandoned
- 2015-06-02 WO PCT/US2015/033827 patent/WO2015187727A2/en not_active Ceased
- 2015-06-02 JP JP2016570087A patent/JP6757935B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017527775A5 (https=) | ||
| Mansoori et al. | Micro-RNAs: The new potential biomarkers in cancer diagnosis, prognosis and cancer therapy | |
| Yeh et al. | Clinical significance of microRNAs in chronic and acute human leukemia | |
| Ha | MicroRNAs in human diseases: from cancer to cardiovascular disease | |
| Słotwiński et al. | MicroRNAs in pancreatic cancer diagnosis and therapy | |
| ES2429404T3 (es) | Procedimientos basados en los microARN para el diagnóstico y el pronóstico del cáncer de pulmón | |
| Oom et al. | MicroRNAs: novel players in cancer diagnosis and therapies | |
| JP5395439B2 (ja) | 固形癌の診断及び治療のためのマイクロｒｎａに基づく方法及び組成物 | |
| Sethi et al. | Regulating miRNA by natural agents as a new strategy for cancer treatment | |
| Seven et al. | The role of miRNAs in cancer: from pathogenesis to therapeutic implications | |
| Dimopoulos et al. | Aberrant micro RNA expression in multiple myeloma | |
| Wang et al. | MicroRNAs as regulator of signaling networks in metastatic colon cancer | |
| Neelakandan et al. | Emerging roles for modulation of microRNA signatures in cancer chemoprevention | |
| JP2015504307A5 (https=) | ||
| RU2013143797A (ru) | Способ выбора пищевого рациона, обеспечивающего получение молока, обладающего иммунорегуляторным действием | |
| JP2009507918A5 (https=) | ||
| JP2011511634A5 (https=) | ||
| JP2009100687A5 (https=) | ||
| D&aposAngelo et al. | MicroRNAs as tools and effectors for patient treatment in gastrointestinal carcinogenesis | |
| Emmett et al. | An update on cellular MicroRNA expression in human papillomavirus-associated head and neck squamous cell carcinoma | |
| Juneja et al. | MicroRNAs and noncoding RNAs as gene regulators and potential therapeutic agents | |
| Drillis et al. | Non-coding RNAs (miRNAs and lncRNAs) and their roles in lymphogenesis in all types of lymphomas and lymphoid malignancies | |
| Li et al. | The expression and functions of microRNAs in pancreatic adenocarcinoma and hepatocellular carcinoma | |
| Panarelli et al. | MicroRNA expression in selected carcinomas of the gastrointestinal tract | |
| Sheervalilou et al. | A review on microRNAs’ function, detection and evaluation methods, expression dysregulation mechanisms and possible applications in clinical phase as diagnostic, prognostic and therapeutic biomarkers of lung cancer patients |